FDG-PET can show anteroposterior glucose metabolism gradient in anti-NMDAr encephalitis, but there are also suggestions that basal ganglia are involved. We examined FDG-PET scans in 5 consecutive episodes of serologically proven anti-NMDAr encephalitis, compared with healthy controls. We confirmed the anteroposterior metabolic gradient and found a significant FDG uptake increase in the caudate nuclei in episodes of varying intensity and delay from the onset of the symptoms. FDG-PET can be useful in the work-up of suspected anti-NMDAr encephalitis disclosing a characteristic cortical and sub-cortical metabolism pattern.
Introduction
Encephalitis with anti-NMDA receptor antibodies is a recently described subacute severe condition occurring typical in young women. Its course follows typically a progression with initially prominent psychiatric symptoms followed by seizures, movement disorders, and eventually consciousness impairment, as well as dysautonomia (mostly hypoventilation) (Graus et al., 2008) . The exact incidence of the condition is unknown but it could represent up to 20% of encephalitis seen in tertiary centres (Irani et al., 2010) . The predominance of psychiatric symptoms observed at the time of onset, can make the identification of the condition challenging and lead to delays. MRI structural imaging does usually not show significant abnormalities and finding anti-NMDA receptor antibodies is cerebrospinal fluid (CSF)/serum is diagnostic. Suggestive EEG pattern were also reported ("extreme delta brushes") but their specificity and sensibility are unknown (Schmitt et al., 2012) . As a proportion of cases are paraneoplastic (Tuzun et al., 2009 ), 18F-fluorodeoxyglucose (FDG) positron emission tomography (PET) was used to screen potential neoplasia in those patients. Several reports also showed a characteristic cerebral FDG-PET pattern in this condition with a hypermetabolism in anterior regions of frontal and temporal lobes compared to a relative hypometabolism in posterior regions (Leypoldt et al., 2012) . There are however evidences of subcortical structures involvement, clinically with the occurrence of movement disorders (Stamelou et al., 2012) , as well as in MR imaging studies (Gunther et al., 2012; Tzoulis et al., 2013) . Our group previously suggested FDG-PET hyperactivity in basal ganglia (Maeder-Ingvar et al., 2011) . The determination of a specific FDG uptake pattern could add a diagnostic tool alongside the auto-antibodies level to help early diagnosis and to monitor the disease activity during the commonly prolonged treatment. FDG-PET uptake pattern could also be a tool to further stratify/phenotype episodes of anti-NMDAr encephalitis.
In order to explore the FDG-PET pattern associated with episode of anti-NMDAr encephalitis, we reviewed the FDG-PET brain scans of all episodes admitted in our centre and the regional uptake was matched with normal controls.
Material and methods
We retrospectively reviewed the FDG PET results of 5 episodes of anti-NMDAr antibodies encephalitis in 4 patients. To ascertain that the exam was performed in interictal state all PET scan were performed under EEG monitoring since the beginning of rest before the radiopharmaceutical injection to the begin of PET acquisition. After 20 min of rest, with closed eyes in a quiet and dark room, an intravenous injection of 150 to 250 MBq of 18F-FDG was performed. Patients were waiting for 20 more minutes in the same environment. A 20 minutes 3D PET image of the brain has been acquired (Discovery 690 VCT, GE Healthcare, Milwaukee, Wisconsin, USA). All patients had a brain MRI as part of the clinical evaluation; T1 weighted images were fused to the FDG PET using the PMOD Software (version 3.403, PMOD
